Exhibit 10.3
BIONEUTRAL
GROUP, INC.
RESTRICTED
STOCK UNIT AGREEMENT
THIS
RESTRICTED STOCK UNIT AGREEMENT (this
“ Agreement ”) is entered into as of the 3rd day
of February, 2010, by and between BioNeutral Group, Inc., a Nevada
corporation (the “ Company ”), and Chertoff
Group, L.L.C., a Delaware limited liability company (the “
Grantee ”).
WHEREAS,
this
Agreement evidences an equity award the Company is obligated to
grant to Advisor pursuant to that certain Advisory Agreement, dated
as of August 26, 2009, by and between the Company and the Advisor,
as amended from time to time (the " Advisory Agreement
").
NOW,
THEREFORE, for
and in consideration of the mutual promises herein contained, and
for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties hereto
hereby agree as follows:
|
|
Grant
of Restricted Stock Units .
|
Subject
to the restrictions and other conditions set forth herein, the
Board of Directors of the Company (the “ Board
”) hereby grants to the Grantee on February 3, 2010 (the
“ Grant Date ”) the right to receive the
Applicable Number of Shares of Common Stock on the Delivery Date to
the extent then vested (the “ Restricted Stock Units
”). For purposes hereof, (i) the “
Applicable Number of Shares of Common Stock ” means
the number of shares of Common Stock equal to A divided by B, where
A equals $1,384,346.85, and B equals the greater of (x) the Fair
Market Value of a share of Common Stock on the Delivery Date and
(y) $0.186, and (ii) the “ Delivery Date ” means
the earlier to occur of January 2, 2013 and the date that is
immediately prior to a Change in Control.
(a)
Normal Vesting . Except as set forth in Section
2(b) hereof, the Restricted Stock Units shall vest on a cumulative
basis as set forth below, subject to the Grantee’s continued
service with the Company or any of its affiliates on each
applicable vesting date:
|
Vesting
Date
|
Cumulative
Percentage of Units Vested
|
|
September
1, 2010
|
25
%
|
|
September
1, 2011
|
50
%
|
|
September
1, 2012
|
100%
|
(b)
Accelerated Vesting . Notwithstanding the vesting
provisions of Section 2(a) hereof, the Restricted Stock Units shall
become fully vested upon the earlier to occur of (i) the
consummation of a “Change in Control” (as defined
below) or (ii) the termination of the Grantee’s service by
the Company on or after February 26, 2010 pursuant to Section
4(b)
of the
Advisory Agreement. In the event that the Grantee
voluntarily resigns the Grantee’s service with the Company on
or after February 26, 2010, the Grantee shall be obligated to
refund to the Company the after-tax value of any portion of the
Restricted Stock Units that vested and for which the Company issued
the underlying shares of Common Stock during the three-month period
preceding such termination ( provided that such refund
obligation shall not be required if such termination of service
occurs within three months prior to a Change in
Control). This Agreement shall not in any way affect the
right of the Company to adjust, reorganize or otherwise change its
capital or business structure or to merge, consolidate, dissolve,
liquidate or sell or transfer all or any part of its business or
assets.
For
purposes hereof, the term “ Change in Control ”
shall mean:
(i)
any
“person,” as such term is used in Sections 13(d) and
14(d) of the Securities Exchange Act of 1934, as amended (the
“ Exchange Act ”) (other than (A) the Company,
(B) any trustee or other fiduciary holding securities under any
employee benefit plan of the Company, or (C) any company owned,
directly or indirectly, by the stockholders of the Company in
substantially the same proportions as their ownership of Common
Stock of the Company, becoming the beneficial owner (as defined in
Rule 13d-3 under the Exchange Act), directly or indirectly, of
securities of the Company representing 35% or more of the combined
voting power of the Company’s then outstanding
securities;
(ii)
during
any period of two consecutive years, individuals who at the
beginning of such period constitute the Board and any Approved
Directors (collectively, the “Incumbent Directors”)
cease to constitute a majority of the Board (an “Approved
Director” being defined to mean any person whose election to
the Board or nomination for election by the Company’s
stockholders was approved by a vote of (x) at least two-thirds of
the Incumbent Directors or (y) all of the
Incumbent Directors who are directors at the time of
such election; provided that any person designated by a
person who has entered into an agreement with the Company to effect
a transaction described in paragraph (i), (iii), or (iv) of this
definition or a person whose initial assumption of office occurs as
a result of either an actual or threatened election contest or
other actual or threatened solicitation of proxies or consents by
or on behalf of a person other than the Board) shall not be
considered to be an Approved Director);
(iii)
a
merger or consolidation of the Company or a direct or indirect
subsidiary of the Company with any other entity, other than a
merger or consolidation which would result in the voting securities
of the Company outstanding immediately prior thereto continuing to
represent (either by remaining outstanding or by being converted
into voting securities of the surviving entity) more than 50% of
the combined voting power of the voting securities of the Company
or the ultimate parent company of the Company (or, in each case,
the entity surviving any merger with the Company); provided
, however , that a merger or consolidation effected to
implement a recapitalization of the Company (or similar
transaction) in which no person (other than those covered by the
exceptions in paragraph (i) of this definition) acquires more than
50% of the combined voting power of the Company’s then
outstanding securities shall not constitute a Change in Control of
the Company; or
(iv)
a
complete liquidation or dissolution of the Company or the
consummation of a sale or disposition of all or substantially all
of the assets of the Company and its direct and indirect
subsidiaries on a consolidated basis other than the sale or
disposition of all or substantially all of such assets to a person
or persons who beneficially own, directly or indirectly, 50% or
more of the combined voting power of the outstanding voting
securities of the Company immediately prior to such
sale.
Notwithstanding
anything to the contrary contained herein, the Grantee shall be
permitted to participate in any Change in Control involving a
merger of the Company or any of its subsidiaries that affects or
involves the Common Stock or tender offer or other general offer to
purchase, acquire, exchange or convert shares of Common Stock with
respect to shares of Common Stock subject to outstanding Restricted
Stock Units on a contingent basis ( i.e. , by allowing the
Grantee to receive all or a portion of the Applicable Number of
Shares of Common Stock contingent upon consummation of such
transaction and to receive the per share consideration payable in
respect of such transaction for the Applicable Number of Shares of
Common Stock).
(c)
Distribution of Restricted Stock Units . Subject
to the provisions of Section 2(d) hereof, the Grantee shall receive
the number of shares of common stock of the Company, par value
$.00001 per share (the “ Common Stock ”), that
correspond to the number of Restricted Stock Units that have become
vested on the Delivery Date. For purposes hereof, the
term “ Fair Market Value ” shall mean, as of any
date, the last sales price reported for the Common Stock on the
applicable date: (A) as reported on the principal
national securities exchange in the United States on which it is
then traded, (B) if the Common Stock is traded on the OTC
Bulletin Board, the closing bid price of the Common Stock for such
date (or the nearest preceding date) on the OTC Bulletin Board,
(C) if the Common Stock is not then listed or quoted for
trading on the OTC Bulletin Board and if prices for the Common
Stock are then reported in the “Pink Sheets” published
by Pink OTC Markets, Inc. (or a similar organization or agency
succeeding to its functions of reporting prices), the most recent
bid price per share of the Common Stock so reported, or (D) if the
Common Stock is not traded, listed or otherwise reported or quoted,
Fair Market Value shall be determined without applying minority
interest, lack of liquidity or other similar discounts by a
nationally recognized, independent appraisal firm mutual